CINECA IRIS Institutional Research Information System

MARTELLI, ALMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.824
AS - Asia 7.423
EU - Europa 5.660
SA - Sud America 962
AF - Africa 305
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 28.197
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.388
SG - Singapore 2.400
IT - Italia 2.198
CN - Cina 2.063
HK - Hong Kong 1.121
BR - Brasile 794
VN - Vietnam 740
SE - Svezia 703
DE - Germania 678
BG - Bulgaria 402
CA - Canada 337
FR - Francia 314
GB - Regno Unito 304
FI - Finlandia 253
TR - Turchia 236
RU - Federazione Russa 195
IN - India 160
JP - Giappone 160
AT - Austria 156
KR - Corea 137
CI - Costa d'Avorio 125
PL - Polonia 101
UA - Ucraina 93
NL - Olanda 72
BD - Bangladesh 69
IQ - Iraq 54
MX - Messico 52
AR - Argentina 50
CH - Svizzera 48
ZA - Sudafrica 38
PK - Pakistan 30
UZ - Uzbekistan 30
SA - Arabia Saudita 29
SN - Senegal 29
BE - Belgio 25
EC - Ecuador 24
VE - Venezuela 24
ES - Italia 23
CO - Colombia 22
ID - Indonesia 19
MA - Marocco 18
KE - Kenya 17
TW - Taiwan 17
EG - Egitto 15
JO - Giordania 15
MY - Malesia 15
PH - Filippine 15
TN - Tunisia 15
NG - Nigeria 14
AU - Australia 13
IR - Iran 13
PE - Perù 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
CZ - Repubblica Ceca 12
IL - Israele 11
JM - Giamaica 11
LT - Lituania 11
AZ - Azerbaigian 10
HU - Ungheria 10
KZ - Kazakistan 10
PS - Palestinian Territory 10
GR - Grecia 9
PY - Paraguay 9
DZ - Algeria 8
BO - Bolivia 7
IE - Irlanda 7
KG - Kirghizistan 7
UY - Uruguay 7
CR - Costa Rica 6
HR - Croazia 6
OM - Oman 6
AL - Albania 5
NP - Nepal 5
PT - Portogallo 5
AO - Angola 4
BJ - Benin 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EU - Europa 4
GT - Guatemala 4
HN - Honduras 4
LB - Libano 4
LK - Sri Lanka 4
LU - Lussemburgo 4
MD - Moldavia 4
RO - Romania 4
AM - Armenia 3
ET - Etiopia 3
GH - Ghana 3
MK - Macedonia 3
NI - Nicaragua 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
YE - Yemen 3
BB - Barbados 2
Totale 28.158
Salva come PNG Salva come JPEG
Città #
Ashburn 1.393
Singapore 1.364
Woodbridge 1.143
Hong Kong 1.092
Ann Arbor 968
Fairfield 901
San Jose 847
Chandler 734
Santa Clara 734
Dallas 706
Houston 681
Serra 491
Beijing 420
Seattle 405
Milan 401
Sofia 401
Shanghai 389
Wilmington 338
Cambridge 303
New York 299
Boardman 263
Ottawa 248
Los Angeles 218
Hefei 197
Council Bluffs 196
Princeton 172
Ho Chi Minh City 161
Lawrence 157
Frankfurt am Main 146
Vienna 142
Lauterbourg 140
Tokyo 138
Hanoi 137
Izmir 133
Chicago 131
Medford 127
Abidjan 125
Seoul 123
Nanjing 122
Munich 120
Jacksonville 112
Pisa 110
Dong Ket 106
Helsinki 97
Rome 94
Des Moines 90
Buffalo 89
London 86
Warsaw 83
Florence 81
Istanbul 69
São Paulo 65
Redondo Beach 64
San Diego 57
Orem 54
Dearborn 42
Marseille 42
Boulder 41
Redwood City 40
Salt Lake City 40
Da Nang 37
Livorno 36
Nanchang 36
Columbus 35
Ogden 34
Lucca 32
The Dalles 32
Naples 30
Dakar 29
Washington 29
Changsha 28
Turku 28
Phoenix 27
Shenyang 27
Tianjin 27
Zurich 27
Fuzhou 25
Nürnberg 24
Tashkent 24
Amsterdam 23
Atlanta 23
Brussels 23
Guangzhou 23
Lappeenranta 23
Montreal 23
Nuremberg 23
Bremen 22
Brooklyn 22
Chennai 22
Lancaster 22
Pune 22
Rio de Janeiro 22
Toronto 22
Kunming 21
Johannesburg 20
Quanzhou 20
Baltimore 19
Bern 19
Düsseldorf 19
Haiphong 19
Totale 19.687
Salva come PNG Salva come JPEG
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 393
Vascular Effects of p-Carboxyphenyl-Isothiocyanate, a novel H2S-donor 308
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme 303
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 299
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 299
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 293
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 288
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 257
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 248
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 242
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 237
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 234
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 232
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 226
Metformin conjugates and therapeutic use thereof 225
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 224
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 222
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 222
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 222
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 220
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 215
Impact of thermal processing on polyphenols, carotenoids, glucosinolates, and ascorbic acid in fruit and vegetables and their cardiovascular benefits 214
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 214
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 207
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 204
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 203
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 203
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 199
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 199
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 198
Resveratrol-like Compounds as SIRT1 Activators 195
Alteration of endogenous purinergic modulation of tracheal neurotransmission in sensitised guinea-pigs 194
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 194
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 192
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 188
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 186
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 185
New amido derivatives as potential BKCa potassium channel activators. XI 184
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 183
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 181
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 180
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 179
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 179
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 179
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro 178
Anti-Inflammatory and Vasorelaxant Effects Induced by an Aqueous Aged Black Garlic Extract Supplemented with Vitamins D, C, and B12 on Cardiovascular System 176
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 175
Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes. 174
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 174
NO-Sartans: A New Class of Pharmacodynamic Hybrids as Cardiovascular Drugs 173
Large conductance Ca2+-activated K+ channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects 173
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 173
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 172
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 172
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 171
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 170
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 170
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 169
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 165
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 162
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 159
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 159
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 153
Enantioresolution, stereochemical characterization and biological activity of a chiral large-conductance calcium-activated potassium channel opener 153
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 153
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives 151
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 151
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 151
Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis 150
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs 149
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 148
Evaluation of the NO-releasing properties of NO-donor linkers 147
The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury 147
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 146
Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels 146
ACTIVATION OF VASCULAR KV7 POTASSIUM CHANNELS CONTRIBUTES TO THE VASODILATOR EFFECTS OF HYDROGEN SULPHIDE 145
Expression and function of Kv7.4 channels in rat cardiac mitochondria: possible targets for cardioprotection 145
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 144
Pathophysiological role of mitochondrial potassium channels and their modulation by drugs 144
EFFECTS OF TSPO-LIGANDS ON MITOCHONDRIAL VOLUME AND MITOCHONDRIAL MEMBRANE POTENTIAL 142
HYDROGEN SULPHIDE: NOVEL OPPORTUNITY FOR DRUG DISCOVERY 142
CARDIOVASCULAR EFFECTS OF A NEW NO-RELEASING COXIB DERIVATIVE 140
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 140
Efficacy of isothiocyanate-based compounds on different forms of persistent pain 138
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 136
Persulfidation of mitoKv7.4 channels contributes to the cardioprotective effects of the H2S-donor Erucin against ischemia/reperfusion injury 135
IMPROVING THE SOLUBILITY OF A NEW CLASS OF ANTIINFLAMMATORY PHARMACODYNAMIC HYBRIDS, THAT RELEASE NITRIC OXIDE AND INHIBIT CYCLOXYGENASE-2 ISOENZYME 135
New Synthetic Analogues of Natural Polyphenols as Sirtuin 1-Activating Compounds 135
The Efficacy of Camelina sativa Defatted Seed Meal against Colitis-Induced Persistent Visceral Hypersensitivity: The Relevance of PPAR α Receptor Activation in Pain Relief 134
Pharmacodynamic hybrids coupling established cardiovascular mechanisms of action with additional nitric oxide releasing properties 134
(+/-)-NARINGENIN AS KCA 1.1 CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 133
QSAR Studies on BK Channel Activators 133
Anomalous Kv7 channel activity in human malignant hyperthermia syndrome unmasks a key role for H2S and persulfidation in skeletal muscle 133
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: DIARYLPYRROLE ACETIC ACID ESTERS ENDOWED WITH NITRIC OXIDE RELEASING PROPERTIES 132
Structural modifications of benzanilide derivatives, effective potassium channel openers. X 131
Pharmacodynamic hybrids with insulin secretagogue and NO-Donor activity 130
Cardioprotective effects of different flavonoids against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts. 130
In-vitro evaluation of new pharmacodynamic hybrids with insulin secretagogue and NO-donor activity 129
NO-Releasing Hybrids of Cardiovascular Drugs 129
NO-releasing hybrids of cardiovascular drugs 129
Totale 18.257
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.731
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 0 0 0 0 0 0 0 0 0 0 0 268
2021/20221.811 36 137 51 77 300 289 54 95 89 59 137 487
2022/20232.582 297 340 166 211 266 342 20 169 549 17 122 83
2023/20241.858 161 231 222 108 269 333 96 54 30 39 94 221
2024/20256.265 65 252 94 351 526 709 453 349 595 799 814 1.258
2025/20267.880 391 901 805 613 821 684 1.369 416 584 772 284 240
Totale 28.847